FDA Investigator Kara A Scheibner, PhD
Kara A Scheibner, PhD has conducted inspections on 28 sites in 6 countries as of 03 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
28
Last Inspection Date:
03 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Netherlands,
Switzerland,
Canada,
France
FDA Investigators that have inspected at least one site in common with Kara A Scheibner, PhD:
Aimee Cunningham, PhD,
Alan P Kurtzberg,
Alanna L Mussawwir Bias,
Allen F Hall,
Amanda E Lewin, PhD,
Amy Devlin, PhD,
Andrea A Branche,
Anissa M Cheung,
Anita R Michael,
Arie C Menachem,
Arindam Dasgupta, PhD,
Barbara T Carmichael,
Benton M Ketron,
Bonita S Chester,
Brandy D Brown,
Brenda P King,
Brentley S Collins,
Brett R Havranek,
Burnell M Henry,
Byungja E Marciante,
Camerson E Moore,
Charles A Snipes, PhD,
Charles R Bonapace, PhD,
Charles R Cote, RIC,
Chase Bourke, PhD,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christopher Downey, PhD,
Clotia Cabbey Mensah,
Corey K Reno,
Courtney N Long,
Craig A Garmendia,
Cynthia White,
Daniel L Aisen,
David M Mcnew,
David R Heiar,
Dawn C Olenjack,
Dawn L Wydner,
Dawn M Braswell,
Denise L Burosh,
Denise M Digiulio,
Denise M Visco, Investigator,
Dina A Tallman,
Douglas A Campbell,
Dr. Abhijit Raha, PhD,
Dr. Gopa Biswas, PhD,
Dr. Mark J Seaton, PhD,
Dr. Sriram Subramaniam, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Dylan D Yao, MD, PhD,
Edward D Harris,
Edward D Vains,
Ekaterina Allen,
Ellen P Madigan,
Eric M Mueller, PharmD,
Farhana Khan,
Felix Maldonado,
Gabriel Davila,
Gajendiran Mahadevan, PhD,
Gary T Greco,
Gene D Arcy,
Gene R Gunn,
Geoffrey K Kilili,
George C Amedro,
Gerald N Mcgirl, DDS,
Gregory W Smith,
Guerlain Ulysse,
Gulshan R Anand,
Gunther Boekhoudt, PhD,
Hanna L Potter,
Hasan A Irier, PhD,
Hector Jcolon Torres,
Himanshu Gupta, PhD,
Humberto Z Gomez,
Hyojong Kwon, PhD,
Jacqueline A O'shaughnessy, PhD,
Jacqueline Mdiaz Albertini,
James M Mason,
Janete F Guardia,
Jasjeet K Sekhon,
Jean M Kelahan,
Jeanne J Thai,
Jee Chung, PhD,
Jennifer C Adams,
Joanne M Schlossin,
John S Hartford,
Jonee J Mearns,
Jose A Lopez,
Joseph L Despins, PhD,
Joyce A Rockwell,
Julie D Bringger,
Junho Pak,
Justine M Corson,
Jyoti B Patel, PhD,
Ka L Wong,
Karen L Kosar,
Kathleen R Jones, PhD,
Kathryn A Krentz,
Kerun Hardeo,
Kevin A Gonzalez,
Kimberly A Dux,
Kip J Hanks,
Kirtida Patel,
Lakecha N Lewis,
LCDR Chad N Thompson,
LCDR Debra Emerson,
Li Hongpaul Yeh, PhD,
Linda R Kuchenthal,
Makini Cobourne Duval, PhD,
Marc R Dickens,
Marcelo O Mangalindan, Jr,
Margaret E Sarles,
Margaret M Sands,
Marion W Nadeau,
Martha T Olone,
Martin K Yau, PhD,
Matthew C Watson,
Maxwell Van Tassell, PhD,
Megan A Haggerty,
Melkamu Getie Kebtie, PhD,
Michael F Skelly, PhD,
Michael G Sinkevich,
Michael P Anthony,
Michael Serrano,
Michelle M Noe Varga,
Mike M Rashti,
Mohsen Rajabi Abhari, FDA,
Monique C Lo,
Nailing Zhang,
Nerizza B Dalena,
Nerizza B Guerin,
Nicholas C Mendiola,
Nicola M Fenty Stewart,
Nilufer M Tampal, PhD,
Nina Yang,
Niraj R Mehta, PhD,
Ogechi C Nna,
Patrick D Stone, MS,
Paula A Trost,
Perry H Gambrell,
Prabhu P Raju,
Priscilla M Pastrana,
Rafael Padilla,
Rebecca T Davis,
Richard H Penta,
Richard W Thornton,
Robert J Martin,
Roger F Zabinski,
Ronald R Ruff,
Ruben C Ayala, PharmD,
Russ E Davis,
Russell K Riley,
Sam H Haidar, PhD,
Sandra A Hughes,
Sandra S Saniga,
Scott B Laufenberg,
Sean R Marcsisin,
Seongeun Cho (Julia), PhD,
Seth A Mailhot,
Shalonda C Clifford,
Sherri N Rohlf, MD,
Sripal R Mada, PhD,
Stacey S Degarmo,
Stanley Au,
Stephanie Mangigian, MS/OSH, RN,
Stuart W Russell,
Susan D Yuscius,
Susanne M Richardson, MS RAC,
Thea C Grome,
Thomas W Nojek,
Torrance J Slayton,
Tracey L Harris,
Vickie J Kanion,
Victor J Gangi,
Walter N Lange,
Wayne E Seifert,
Wayne T Smith,
Xiaohan Cai, PhD,
Xiaokuang Lai, PhD,
Xikui Chen (nmi), PhD,
Yanming An, PhD,
Yiying E Chen,
Yiyue Zhang (nmi), PhD,
Young M Choi, PhD,
Yumi J Hiramine,
Zhongren Wu
Kara A Scheibner, PhD's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more